APM vs. TXMD, RNXT, BFRG, LSTA, FBRX, ITRM, GDTC, CPIX, ONCT, and UBX
Should you be buying Aptorum Group stock or one of its competitors? The main competitors of Aptorum Group include TherapeuticsMD (TXMD), RenovoRx (RNXT), Bullfrog AI (BFRG), Lisata Therapeutics (LSTA), Forte Biosciences (FBRX), Iterum Therapeutics (ITRM), CytoMed Therapeutics (GDTC), Cumberland Pharmaceuticals (CPIX), Oncternal Therapeutics (ONCT), and Unity Biotechnology (UBX). These companies are all part of the "pharmaceutical preparations" industry.
Aptorum Group (NASDAQ:APM) and TherapeuticsMD (NASDAQ:TXMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, community ranking, analyst recommendations and valuation.
TherapeuticsMD received 345 more outperform votes than Aptorum Group when rated by MarketBeat users. However, 68.33% of users gave Aptorum Group an outperform vote while only 62.46% of users gave TherapeuticsMD an outperform vote.
Aptorum Group's return on equity of 0.00% beat TherapeuticsMD's return on equity.
Aptorum Group has higher earnings, but lower revenue than TherapeuticsMD.
In the previous week, TherapeuticsMD had 5 more articles in the media than Aptorum Group. MarketBeat recorded 7 mentions for TherapeuticsMD and 2 mentions for Aptorum Group. Aptorum Group's average media sentiment score of 1.19 beat TherapeuticsMD's score of 0.88 indicating that Aptorum Group is being referred to more favorably in the media.
3.8% of Aptorum Group shares are held by institutional investors. Comparatively, 30.7% of TherapeuticsMD shares are held by institutional investors. 64.0% of Aptorum Group shares are held by insiders. Comparatively, 1.2% of TherapeuticsMD shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Aptorum Group has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, TherapeuticsMD has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500.
Summary
Aptorum Group beats TherapeuticsMD on 7 of the 12 factors compared between the two stocks.
Get Aptorum Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for APM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptorum Group Competitors List
Related Companies and Tools
